On an autoxidisable constituent of the cell
The high propensity for genetic transformation of meningococcus, a bacterium with minimal genetic barrier to recombination and a unique, non-regulated competence system that allows it to capture DNA throughout the entire growth cycle, is such that this species presents non-clonal, but panmictic characteristics (Maiden, 1993, Maiden, 2006
Under FDA's interim policy, Category 2 substances are not covered by the enforcement-discretion policy that applies to Category 1, and FDA stated it would consider taking action against a compounder for compounding with a Category 2 substance [11]
Common side effects include temporary redness, swelling, discomfort, and tightness in the treated area